Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
Clinical trial NCT07487948 · RECRUITING
Trial details
- NCT number
- NCT07487948
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-19
- Primary completion
- 2027-04-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.